Participating Faculty: Real-World Insights on Biomarker Testing Patterns and Implications for mNSCLC Therapy Selection

Faculty

Amy Stanford, PharmD

Director

Value Strategy & Evidence, US Market Access

AstraZeneca

Wilmington, DE

Shawn Boykin, PhD

Senior Director

Value Strategy & Evidence, US Market Access

AstraZeneca

Wilmington, DE

Karishma Desai, PhD, MS, BPharm

Associate Director

HEOR

Carelon Research

Wilmington, DE

Pritesh S. Karia, PhD, MPH

Associate Director

Oncology Outcomes Research

AstraZeneca

Gaithersburg, MD

Kim C. Ohaegbulam, MD, PhD

Resident Physician

Department of Radiation Medicine

Oregon Health & Science University

Portland, OR

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Amy Stanford, PharmD

EMPLOYMENT

AstraZeneca

STOCK OWNERSHIP

AstraZeneca

Shawn Boykin, PhD

EMPLOYMENT

AstraZeneca

STOCK OWNERSHIP

AstraZeneca

Pritesh S. Karia, PhD, MPH

EMPLOYMENT

AstraZeneca

STOCK OWNERSHIP

AstraZeneca

Karishma Desai, PhD, MS, BPharm, and Kim C. Ohaegbulam, MD, PhD, have no relevant commercial financial relationships or affiliations to disclose.